ZIOPHARM ONCOLOGY INC (ZIOP) Stock Income Statement
NASDAQ:ZIOP - Nasdaq - Common Stock
| TTM (2021-9-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 398.00K | 0.00 | 0.00 | 150.00K | 6.39M | |||
| Operating Expenses | 89.66M | 80.36M | 57.86M | 54.05M | 59.88M | |||
| Research and Development | 55.40M | 52.70M | 38.33M | 34.13M | 45.08M | |||
| Selling, General, and Administrative Expenses | 34.27M | 27.67M | 19.53M | 19.92M | 14.80M | |||
| Operating Income | -89.27M | -80.36M | -57.86M | -53.91M | -53.49M | |||
| Interest Income/Expense | N/A | N/A | 0.00 | 160.00K | -1.30M | |||
| Other Income/Expense | -14.00K | 390.00K | -59.94M | 630.00K | 470.00K | |||
| Income Before Taxes | -89.72M | -79.98M | -117.80M | -53.12M | -54.32M | |||
| Net Income | -89.72M | -79.98M | -117.80M | -53.12M | -54.32M | |||
| EBITDA | -86.95M | -79.23M | -57.23M | -53.33M | -53.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.42 | -0.38 | -0.70 | -0.37 | -0.40 | |||
| Non GAAP EPS | -0.43 | -0.39 | -0.69 | -0.48 | -0.53 | |||
| Statistics | ||||||||
| Profit Margin | -22543.47% | N/A | N/A | -35413.33% | -850.08% | |||
| Operating Profit Margin | -22428.39% | N/A | N/A | -35940.00% | -837.09% | |||
All data in USD